Medicines360 is proud to make an important announcement about LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg
CLICK HERE TO READ THE PRESS RELEASE
We identify areas in women’s health where patients face limited choices, develop medicines that expand women’s options and make them available in ways that close gaps in access. We are leveraging commercial partnerships to offer our first product, a long-acting reversible contraceptive, to safety-net providers at a very low price.
We’re a nonprofit pharmaceutical company that conducts clinical trials, develops medicines, secures regulatory approvals, advocates, educates and expands availability to medicines.
With a blend of clinical, development, financial, commercial, business, legal and policy expertise, the Medicines360 team is forging a new way of doing business to benefit women.
We are committed to closing gaps in women’s health through effective partnerships.
WORK WITH US